T he induction of long-lasting Ab responses that protect from infectious pathogens requires the formation of specialized structures in secondary lymphoid organs, called germinal centers (GCs), where Ig somatic mutation, affinity maturation, and class switch occur (1) . GCs are usually generated as a result of Ag-cognate interactions between a particular subset of CD4 + Th
cells, defined T follicular helper (T FH ) cells, and B cells and depend upon the engagement between CD40L (CD154) on T FH cells and CD40 on B cells
, and the local cytokine environment created by the activated T FH cells (2) . The differentiation of T FH cells depends critically on the expression of the master transcriptional repressor Bcl-6 (3-5) and is characterized by the sustained upregulation of CXCR5, CXCR4, programmed death-1 (PD-1), and ICOS and the production of IL-21 and IL-4, which enable them to migrate to B cell follicles, engage with Ag-activated B cells, and support their proliferation and differentiation into GCs (2). Invariant NKT (iNKT) cells are a distinct subset of T lymphocytes that express the homolog invariant Va14-Ja18 and Va24-JaQ TCR chains in mice and humans, respectively, which pair with diverse TCRb-chains that use Vb8.2, Vb7, and Vb2 in mice and Vb11 in men (6, 7) . The semi-invariant TCR is restricted for CD1d, an MHC class I-like molecule expressed mainly on professional APCs. All iNKT cells recognize the CD1d-restricted strong agonist a-galactosylceramide (aGalCer) (8) . Administration of aGalCer into mice rapidly activates iNKT cells to release copious Th1 and Th2 cytokines, including IL-4 and IL-21, and to upregulate CD40L (8, 9) . As a result, activated iNKT cells license dendritic cells (DCs) via CD40 ligation, enhancing their capacity to induce concomitant Ag-specific CD4 + and CD8 + T cell responses (10) . We have previously shown that activated human iNKT cells provide efficient CD1d-restricted cognate help for proliferation and Ab production by purified B cell in vitro (11) . Furthermore, immunization of mice with protein Ags mixed with aGalCer (aGalCer+Ags) substantially enhanced protective serological immunity and B cell memory (12) . In this immunization model, mouse iNKT cells helped B cells mainly indirectly via licensing of APC functions that resulted in an improved priming of Th cells and enhanced provision of MHC class II (MHC II)-restricted cognate help for B cells (13 
Immunization of mice
Immunizations were performed s.c. at day 0 with Ag dissolved in PBS or mixed with 4 mg aGalCer (Alexis, Lausen, Switzerland). Tail vein blood was drawn at day 7 or 13 to determine primary specific Ab titers. 
mAb treatments in vivo
NK cells or CD8 + T lymphocytes were depleted by injecting i.v. every 2 d anti-AsialoGM1 or anti-CD8a Abs, respectively, beginning at day 27 and continuing up to day 14 from the immunization. To block CD40-CD40L interactions in vivo, 400 mg MR1 anti-CD40L mAb (Taconic Europe, Ejby, Denmark) were given i.p. in 100 ml PBS at days 0, 2, and 4 from the immunization, a schedule optimized to inhibit GC induction (14) .
Measurement of Ag-specific Ab titers
Individual sera were titrated in parallel at the same time for their Ag-specific Ab content by end-point ELISA as described (13) . Ab titers are expressed as reciprocal dilutions giving an OD 450 . mean blank OD 450 + 3 SD. Blanks consistently displayed OD 450 ,0.1 and ,10% variability.
Cell staining and flow cytometry
The following mAb conjugates were used to stain the cells: anti-CD1d-PE, anti-CD40-PE, anti-CD19-APC, anti-TCR-b-Pacific Blue, anti-CD4-allophycocyaninCy7, anti-PD-1-PECy7, anti-CD44-PerCPCy5.5 (BD Biosciences, San Jose, CA), anti-CXCR5-APC, anti-ICOS-FITC (BioLegend), and anti-Bcl-6-FITC (7D1; Santa Cruz Biotechnology). PBS57-loaded mouse CD1d-PE tetramers were obtained from the National Institutes of Health Tetramer Core Facility. Nonspecific binding was blocked with anti-CD16/CD32 24G2 mAb before staining. Stained cells were acquired on FACSCanto flow cytometers (BD Biosciences), excluding nonviable cells and aggregates. Data were analyzed using FlowJo software (Tree Star).
Generation of mixed bone marrow chimeras
Mixed bone marrow chimeras (BMCs) were generated as described (13) .
B cell adoptive transfer
B cells were purified with anti-CD19 magnetic beads (Miltenyi Biotec) from spleens of wild-type (WT) or CD40 2/2 mice. Cell purity (.97%) was confirmed by flow cytometry analysis. A total of 10 7 B cells were injected in the tail vein. Mice were immunized 1 d after the transfer.
Tissue sections and confocal microscopy analysis
Spleens were fixed with phosphate-buffered L-lysine with 1% paraformaldehyde/periodate overnight at 4˚C and then cryoprotected by an ascending series of 10, 20, and 30% sucrose in PBS. Samples were snapfrozen in tissue-freezing liquid (Triangle Biomedical Sciences) and stored at 280˚C. Sections 40-mm thick were mounted on Superfrost Plus slides (Fisherbrand) and stained with fluorescent Abs in a humidified chamber after Fc receptor blockade with 1 mg/ml Ab 2.4G2 (BD Pharmingen). Sections were stained with anti-IgD-FITC (eBioscience), anti-CD4-APC (BD Pharmingen), and Biotinylated-Peanut Agglutinin (Vector Laboratories, Burlingame, CA), followed by streptavidin-AlexaFluor568 (Invitrogen). Samples were mounted in FluorSave reagent solution (EMDCalbiochem) and stored at 4˚C until analysis. Images were collected with a Bio-Rad confocal microscopy system (Bio-Rad) using an Olympus BX50WI microscope (Olympus) and 103/0.4 numerical aperture objective lenses and analyzed by Volocity software.
Statistics
Ab titers were log 10 -transformed and tested for normal distribution by using the Kolmogorov-Smirnov test for continuous variables. Geometric mean Ab titers (GMTs) and the 95% confidence intervals were derived from the anti-log 10 of the mean, and of the mean 6 SD, of the log 10 1 ) and spleen cells from two additional mice sacrificed at the same day of immunization confirmed that the Ab treatment depleted .90% of NK or CD8 + T cells. Both Ab-treated and nontreated control mice were immunized with aGalCer+NP-CGG, and 2 wk later, their sera were collected to determine the NP-specific Ab titers. The Ab responses induced by aGalCer+NP-CGG immunization were comparable in both groups of mice (Fig. 1A) , indicating that iNKT cells dispense help independently of NK or CD8 + T cells. These results also suggested that iNKT cells directly helped Agspecific B cells by a mechanism entailing CD1d-restricted cognate interaction with B cell. To investigate this possibility, we generated mixed BMCs in which lethally irradiated recipient mice lacking both B and CD4 + T cells (mMT˚3 MHC II 2/2 ) were reconstituted with transplanted bone marrow composed by 80% of cells from mMT˚3 MHC II 2/2 mice and by 20% of cells from either WT or CD1d 2/2 mice. The purpose of these chimeras was to generate mice in which: 1) iNKT cells were present; 2) CD4 + T cells were absent because of the lack of MHC II expression on thymic epithelium; 3) the majority of DCs expressed CD1d and presented aGalCer to iNKT cells; and 4) all B cells expressed or did not express CD1d (Fig. 1B) (19) . As shown in Fig. 2A , (Fig. 4B) , consistent with the CD40 engagement on B cells required for Ig class switch (19) . When compared with Ab responses detected in WT controls, however, Ab responses in MHC II 2/2 mice were lower, more transient, and also unresponsive to boosting (Fig. 4B) . This suggests that iNKT FH cells are specialized in initiating the primary B cell response but, in the absence of CD4 + T FH , they cannot sustain the establishment of long-lasting Ab titers.
Discussion
Previous studies have shown that immunization of WT animals with NP-KLH simply mixed with aGalCer elicits Ab responses that require both the expression of CD1d by B cells and the concomitant presence of CD4 + Th cells (22, 23) . Furthermore, immunization of WT animals with B cell Ags chemically conjugated with aGalCer stimulated the delivery of CD1d-restricted cognate help by iNKT cells, which resulted either in marginal zone B cell activation (24) or Ag-specific extrafollicular plasma cell responses (25) . Very recently, a study has been published describing the induction of iNKT FH cells upon immunization of C57BL6 mice with antigenic complexes (the protein hen egg lysozyme directly complexed with aGalCer or the haptenated lipid NP-aGalCer) that do not activate CD4 + T FH cells (26) . Furthermore, a second study has shown that the cognate help delivered by iNKT cells to B cells upon immunization of mice also with NP-aGalCer critically depended on IL-21 produced by iNKT cells, suggesting that iNKT cells display follicular helper cell functions (27) . Our present results not only confirm the direct helper functions of iNKT cells but also extend our understanding of the mechanistics of this phenomenon. We show indeed that iNKT cells can differentiate into specialized T FH effectors upon immunization with protein Ags simply mixed with aGalCer and induce GC formation in the complete absence of CD4 + T FH cells. Consistent with the acquisition of follicular helper functions by iNKT cells, our mixed radiation chimeras and B cell transfer experiments provide direct evidence that iNKT cells deliver CD1d-restricted and CD40-dependent cognate help to B cells.
We previously showed that iNKT cells display their adjuvant effect for Ab production in WT mice in a noncognate manner by facilitating DC priming of CD4 + Th cells, leading in turn to the enhanced delivery of classic help to specific B cells (13 Future studies are needed to address this crucial difference. T FH cell differentiation requires sustained Ag stimulations delivered initially by DCs within the T cell zone, followed by Agactivated B cells first at the T-zone/follicle border and then in the GCs (28) . The anatomical location of iNKT cells in the periarteriolar sheath of the mouse spleen, among conventional T cells and DCs (29) , would favor this complex set of interactions. It is conceivable that iNKT cells receive a strong activation signal delivered by DCs presenting aGalCer bound to CD1d, resulting in the upregulation of CXCR5 and the other follicular helper molecules necessary to reach the follicle and contact the Ag-activated B cells that have also internalized aGalCer and present it on CD1d. This view finds support in the data recently published by Chang et al. (26) , showing the requirement for both the presence of B cells and for CD1d-expressing myelomonocytic APCs to induce and maintain iNKT FH cells. Only T FH cells expressing the highest amount of CXCR5 and Bcl-6 can further reach the GCs (2). We find comparable levels of upregulation of CXCR5 and Bcl-6 by splenic CD4 + T FH and iNKT FH cells in immunized mice, suggesting that both subsets are endowed with a migration potential to follicles and GCs, as shown by Chang et al. (26) .
The recent description of CD4 + CD25 + Foxp3 + regulatory T cells that acquire a CXCR5
hi PD-1 hi T FH phenotype and migrate into GCs, where they maintain self-tolerance and limit the outgrowth of non-Ag-specific B cells rather than activating responses (30, 31) , suggests that different T cell subsets can be co-opted in the T FH differentiation pathway to perform distinct functions in the B cell response. In line with the concept of distinct follicular helper functions, both the recently published data (26, 27) and our present study show that iNKT FH cells induce, although they do not sustain, specific Ab responses.
In conclusion, the cognate or noncognate mechanisms by which iNKT cells can deliver help for B cell responses suggest that the helper ability of iNKT cells is context dependent. From a translational point of view, our findings may have potential implications both for the implementation of vaccine design and our understanding of the natural role for iNKT FH cells in the pathophysiology of protective or autoreactive B cell responses.
